cancer of the voice box laryngeal cancer
Conditions
Interventions
None listed
Sponsors
Universitair Medisch Centrum Groningen (UMCG)
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Newly diagnosed squamous cell laryngeal cancer; Malignancy limited to one side of the larynx; Age =75 years (n=10); Written informed consent; WHO performance status 0-2.
Exclusion criteria
Exclusion criteria: Age >= 65 years and
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identification of protein profile differences between laryngeal cancers of young and elderly patients, by comparing differential expression of proteins in cancer and healthy tissue of the same patients, determined by Liquid Chromatography Tandem Mass Spectometry (LC-MS/MS) using the Orbitrap/qTOF mass analyzer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Identification of differences between protein interaction network in cancer and healthy tissue between elderly and young laryngeal cancer patients, determined by Liquid Chromatography Tandem Mass Spectometry (LC-MS/MS) using the Orbitrap/qTOF mass analyzer. | — |
Countries
Netherlands
Outcome results
None listed